Outfitter Financial LLC Gilead Sciences, Inc. Transaction History

Outfitter Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $3,663 - $4,154	50 Added 0.27%	18,528 $1.5 Million
Q3 2023 Oct 20, 2023	SELL	$73.94 - $80.67 $2,587 - $2,823	-35 Reduced 0.19%	18,478 $1.38 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $2,280 - $2,601	-30 Reduced 0.16%	18,513 $1.43 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $16,621 - $18,937	-215 Reduced 1.15%	18,543 $1.54 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $4,175 - $5,994	-67 Reduced 0.36%	18,758 $1.61 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $23,088 - $26,004	-400 Reduced 2.08%	18,825 $1.16 Million
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $9,407 - $10,677	-145 Reduced 0.75%	19,225 $1.4 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $7,445 - $8,033	110 Added 0.57%	19,370 $1.35 Million
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $8,251 - $9,015	-130 Reduced 0.67%	19,260 $1.33 Million
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $126,600 - $144,450	2,110 Added 12.21%	19,390 $1.25 Million
Q4 2020 Feb 18, 2021	BUY	$56.65 - $64.55 $978,912 - $1.12 Million	17,280 New	17,280 $967,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Outfitter Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Outfitter Financial LLC with notifications on news.